Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
Clinical trial NCT01930188 · COMPLETED
Trial details
- NCT number
- NCT01930188
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2015-10-12
- Enrollment
- 1231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.